Drugs and a Methodological Compendium : From bench to bedside / edited by Vikrant Singh Rajput, Ashish Runthala
Chapter 1.Computational and informatics methodologies in Drug Discovery, with focus on Natural Products -- Chapter 2.Structural biology an essential tool for Drug discovery and Development -- Chapter 3.Bioactivity guided fractionation and identification of bioactive molecules: A basic method in drug discovery -- Chapter 4.In–vitro methodologies for the safety assessment of drugs -- Chapter 5.In-vivo models for evaluation of Drug efficacy: Demand and Challenges -- Chapter 6.Preclinical In vivo Drug Development Studies: Limitations, Model Organisms and Techniques -- Chapter 7.Peptide Based Therapeutics and Drug Delivery Systems -- Chapter 8.Basics of Clinical Drug Development: Clinical Trial and Drug Development -- Chapter 9.Trailblazing contemporary frameworks for drug repurposing: A saga on drugs’ expedition to disinter the veiled destiny -- Chapter 10.Small molecules as promising tool for targeted cancer therapies: an overview of 21st century -- Chapter 11.Nanoparticles for Targeted Drug Delivery Systems with Cancer Therapy in Perspective -- Chapter 12.Biomimetic approach for the controlled drug delivery through 3D bioactive scaffolds: A novel strategy for tissue engineering applications -- Chapter 13.Perspectives on anti-tuberculosis drug discovery -- Chapter 14.Cofactor-Receptor interactions based pharmacophore design for development of novel inhibitors: A case study against Tuberculosis -- Chapter 15.Insilico identification of potential antivirals against SARS-CoV2 main protease and RBD of spike protein – A Drug Repurposing Approach -- Chapter16.Anti-malarial drug discovery and development: from bench to bedside..
This book provides a meticulous view on methodological drug discovery and development insights from bench to bedside. The current book threads almost each step encompassing drug the discovery and development of a molecule. The chapters focus on computational modus operandi, pharmacological optimization approaches, modern high-throughput screening methods and in-vitro procedures, role of structural biologists in drug discovery and development, medicinal chemistry approaches for drug design, formulation and drug delivery, in-vivo evaluations of candidate molecules, clinical trial procedures and others. The book also covers specific case studies, regulatory approval proceedings, and industrial view point alongside the aforementioned conceptual layout. And at the same time, the volume integrates medical, biological, medicinal, pharmacological and computational streams, and it is suggested as an ideal guideline to a wide audience including molecular biologists, biochemist, pharmacologists, medicinal chemist, toxicologists, drug discovery and development researchers, and all other students interested in these disciplines. ..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2023. |
---|---|
Erschienen: |
Singapore: Springer Nature Singapore ; 2023. Singapore: Imprint: Springer ; 2023. |
Ausgabe: |
1st ed. 2023. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rajput, Vikrant Singh [HerausgeberIn] |
---|
Links: |
doi.org [lizenzpflichtig] |
---|
ISBN: |
---|
Themen: |
Biology |
---|
Umfang: |
1 Online-Ressource(XV, 425 p. 1 illus.) |
---|
doi: |
10.1007/978-981-19-7952-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1860528597 |
---|
LEADER | 01000nam a22002652 4500 | ||
---|---|---|---|
001 | 1860528597 | ||
003 | DE-627 | ||
005 | 20230929131550.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230929s2023 si |||||o 00| ||eng c | ||
020 | |a 9789811979521 |9 978-981-19-7952-1 | ||
024 | 7 | |a 10.1007/978-981-19-7952-1 |2 doi | |
035 | |a (DE-627)1860528597 | ||
035 | |a (DE-599)KEP096571330 | ||
035 | |a (DE-He213)978-981-19-7952-1 | ||
035 | |a (EBP)096571330 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XB-SG | ||
072 | 7 | |a TCB |2 bicssc | |
072 | 7 | |a SCI010000 |2 bisacsh | |
245 | 1 | 0 | |a Drugs and a Methodological Compendium |b From bench to bedside |c edited by Vikrant Singh Rajput, Ashish Runthala |
250 | |a 1st ed. 2023. | ||
264 | 1 | |a Singapore |b Springer Nature Singapore |c 2023. | |
264 | 1 | |a Singapore |b Imprint: Springer |c 2023. | |
300 | |a 1 Online-Ressource(XV, 425 p. 1 illus.) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Chapter 1.Computational and informatics methodologies in Drug Discovery, with focus on Natural Products -- Chapter 2.Structural biology an essential tool for Drug discovery and Development -- Chapter 3.Bioactivity guided fractionation and identification of bioactive molecules: A basic method in drug discovery -- Chapter 4.In–vitro methodologies for the safety assessment of drugs -- Chapter 5.In-vivo models for evaluation of Drug efficacy: Demand and Challenges -- Chapter 6.Preclinical In vivo Drug Development Studies: Limitations, Model Organisms and Techniques -- Chapter 7.Peptide Based Therapeutics and Drug Delivery Systems -- Chapter 8.Basics of Clinical Drug Development: Clinical Trial and Drug Development -- Chapter 9.Trailblazing contemporary frameworks for drug repurposing: A saga on drugs’ expedition to disinter the veiled destiny -- Chapter 10.Small molecules as promising tool for targeted cancer therapies: an overview of 21st century -- Chapter 11.Nanoparticles for Targeted Drug Delivery Systems with Cancer Therapy in Perspective -- Chapter 12.Biomimetic approach for the controlled drug delivery through 3D bioactive scaffolds: A novel strategy for tissue engineering applications -- Chapter 13.Perspectives on anti-tuberculosis drug discovery -- Chapter 14.Cofactor-Receptor interactions based pharmacophore design for development of novel inhibitors: A case study against Tuberculosis -- Chapter 15.Insilico identification of potential antivirals against SARS-CoV2 main protease and RBD of spike protein – A Drug Repurposing Approach -- Chapter16.Anti-malarial drug discovery and development: from bench to bedside. | ||
520 | |a This book provides a meticulous view on methodological drug discovery and development insights from bench to bedside. The current book threads almost each step encompassing drug the discovery and development of a molecule. The chapters focus on computational modus operandi, pharmacological optimization approaches, modern high-throughput screening methods and in-vitro procedures, role of structural biologists in drug discovery and development, medicinal chemistry approaches for drug design, formulation and drug delivery, in-vivo evaluations of candidate molecules, clinical trial procedures and others. The book also covers specific case studies, regulatory approval proceedings, and industrial view point alongside the aforementioned conceptual layout. And at the same time, the volume integrates medical, biological, medicinal, pharmacological and computational streams, and it is suggested as an ideal guideline to a wide audience including molecular biologists, biochemist, pharmacologists, medicinal chemist, toxicologists, drug discovery and development researchers, and all other students interested in these disciplines. . | ||
650 | 0 | |a Biotechnology. | |
650 | 0 | |a Drug delivery systems. | |
650 | 0 | |a Biology. | |
650 | 0 | |a Pharmaceutical chemistry. | |
650 | 0 | |a Medicine | |
650 | 0 | |a Biology | |
700 | 1 | |a Rajput, Vikrant Singh |e herausgeberin |4 edt | |
700 | 1 | |a Runthala, Ashish |e herausgeberin |4 edt | |
776 | 1 | |z 9789811979514 | |
776 | 1 | |z 9789811979538 | |
776 | 1 | |z 9789811979545 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789811979514 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789811979538 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789811979545 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-981-19-7952-1 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
912 | |a ZDB-2-SEB |b 2023 | ||
912 | |a ZDB-2-SBL |b 2023 | ||
912 | |a ZDB-2-SXB |b 2023 | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a GBV_ILN_22_i06404 | ||
912 | |a GBV_ILN_23 | ||
912 | |a ISIL_DE-830 | ||
912 | |a GBV_ILN_34 | ||
912 | |a ISIL_DE-18-302 | ||
912 | |a GBV_ILN_62 | ||
912 | |a ISIL_DE-28 | ||
912 | |a GBV_ILN_65 | ||
912 | |a ISIL_DE-3 | ||
912 | |a GBV_ILN_100 | ||
912 | |a ISIL_DE-Ma9 | ||
912 | |a GBV_ILN_101 | ||
912 | |a ISIL_DE-Ma14 | ||
912 | |a GBV_ILN_120 | ||
912 | |a ISIL_DE-715 | ||
912 | |a GBV_ILN_130 | ||
912 | |a ISIL_DE-700 | ||
912 | |a GBV_ILN_132 | ||
912 | |a ISIL_DE-959 | ||
912 | |a GBV_ILN_186 | ||
912 | |a ISIL_DE-519 | ||
912 | |a GBV_ILN_285 | ||
912 | |a ISIL_DE-517 | ||
912 | |a GBV_ILN_381 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a ISIL_DE-25 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a ISIL_DE-14 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a ISIL_DE-15 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a ISIL_DE-90 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a ISIL_DE-93 | ||
912 | |a GBV_ILN_2017 | ||
912 | |a ISIL_DE-576 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a ISIL_DE-Fn1 | ||
912 | |a GBV_ILN_2108 | ||
912 | |a ISIL_DE-991 | ||
912 | |a GBV_ILN_2119 | ||
912 | |a ISIL_DE-943 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a ISIL_DE-Ofb1 | ||
951 | |a BO | ||
953 | |2 045F |a 660.6 | ||
980 | |2 22 |1 01 |x 0018 |b 4380465659 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h h64 Springer Biomedical |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 01-10-23 | ||
980 | |2 23 |1 01 |x 0830 |b 4380468356 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h olr-springer |u i |y z |z 01-10-23 | ||
980 | |2 34 |1 01 |x 3551 |b 4380454916 |h OLR-SEB-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi002 |z 01-10-23 | ||
980 | |2 62 |1 01 |x 0028 |b 4380480143 |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 01-10-23 | ||
980 | |2 65 |1 01 |x 0003 |b 4380482553 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 01-10-23 | ||
980 | |2 100 |1 01 |x 3100 |b 4380474844 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 01-10-23 | ||
980 | |2 101 |1 01 |x 3101 |b 4380476723 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 01-10-23 | ||
980 | |2 120 |1 01 |x 0715 |b 4399387416 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 28-10-23 | ||
980 | |2 130 |1 01 |x 0700 |b 4380478874 |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 01-10-23 | ||
980 | |2 132 |1 01 |x 0959 |b 4380446417 |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y k |z 01-10-23 | ||
980 | |2 186 |1 01 |x 0519 |b 4380458822 |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 01-10-23 | ||
980 | |2 285 |1 01 |x 0517 |b 4380479390 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 01-10-23 | ||
980 | |2 381 |1 01 |x 4381 |b 4380453766 |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 01-10-23 | ||
980 | |2 2003 |1 01 |x DE-25 |b 4380081311 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Universitätslizenz |y l01 |z 29-09-23 | ||
980 | |2 2006 |1 01 |x DE-14 |b 4380109496 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 29-09-23 | ||
980 | |2 2010 |1 01 |x DE-15 |b 4380109518 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 29-09-23 | ||
980 | |2 2014 |1 01 |x DE-90 |b 4380109526 |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l01 |z 29-09-23 | ||
980 | |2 2015 |1 01 |x DE-93 |b 4380109534 |c 00 |f --%%-- |d --%%-- |e p |j --%%-- |k Campuslizenz |y l01 |z 29-09-23 | ||
980 | |2 2017 |1 01 |x DE-576 |b 4380109542 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 29-09-23 | ||
980 | |2 2068 |1 01 |x DE-Fn1 |b 438008132X |c 00 |f --%%-- |d eBook Springer |e --%%-- |j en |y l01 |z 29-09-23 | ||
980 | |2 2108 |1 01 |x DE-991 |b 4380081338 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j kp |k Elektronischer Volltext - Campuslizenz |y l01 |z 29-09-23 | ||
980 | |2 2119 |1 01 |x DE-943 |b 4380081346 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 29-09-23 | ||
980 | |2 2129 |1 01 |x DE-Ofb1 |b 4511788308 |c 00 |f --%%-- |d E-Book Springer |e --%%-- |j n |y l01 |z 15-04-24 | ||
981 | |2 22 |1 01 |x 0018 |y Volltextzugang |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 23 |1 01 |x 0830 |y Springer EBook |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 34 |1 01 |x 3551 |y Zugriff nur im dem Netz der HAW-Hamburg |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 100 |1 01 |x 3100 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 100 |1 01 |x 3100 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 101 |1 01 |x 3101 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 101 |1 01 |x 3101 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991016291667203501 | ||
981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 132 |1 01 |x 0959 |y Zugriff nur für Angehörige der Hochschule Osnabrück im Hochschulnetz |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 186 |1 01 |x 0519 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 285 |1 01 |x 0517 |y E-books (Springer) |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 381 |1 01 |x 4381 |y Zugriff nur für GEOMAR-Mitarbeiter / Access for GEOMAR employees only |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2003 |1 01 |x DE-25 |r https://www.redi-bw.de/start/unifr/EBooks-springer/10.1007/978-981-19-7952-1 | ||
981 | |2 2006 |1 01 |x DE-14 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2015 |1 01 |x DE-93 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2068 |1 01 |x DE-Fn1 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2108 |1 01 |x DE-991 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2119 |1 01 |x DE-943 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
981 | |2 2129 |1 01 |x DE-Ofb1 |r https://doi.org/10.1007/978-981-19-7952-1 | ||
982 | |2 132 |1 01 |x 0959 |8 00 |a EBooks Springer Biomedical and Life Sciences | ||
985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
995 | |2 22 |1 01 |x 0018 |a h64 Springer Biomedical | ||
995 | |2 23 |1 01 |x 0830 |a olr-springer | ||
995 | |2 34 |1 01 |x 3551 |a OLR-SEB-SBL | ||
995 | |2 65 |1 01 |x 0003 |a OLR-SEB-ZDB-2-SBL | ||
995 | |2 100 |1 01 |x 3100 |a OLR-SEB | ||
995 | |2 101 |1 01 |x 3101 |a OLR-SEB | ||
995 | |2 120 |1 01 |x 0715 |a alma | ||
995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
995 | |2 132 |1 01 |x 0959 |a OLR-ESP-SBL | ||
995 | |2 132 |1 01 |x 0959 |a OLR-ESP | ||
995 | |2 186 |1 01 |x 0519 |a OLR-SEB | ||
995 | |2 285 |1 01 |x 0517 |a OLR-ESP-SBL | ||
995 | |2 381 |1 01 |x 4381 |a OLR-SEB | ||
998 | |2 23 |1 01 |x 0830 |0 2023.10.01 | ||
998 | |2 2003 |1 01 |x DE-25 |0 29-09-23 |f 17 |